A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders — FORWARD

Fatty Acid Oxidation Disorder Clinical Trial

Official title:
A Prospective, Multicenter, Non-interventional Study to Investigate the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders (FAOD)

Status Completed

Clinical Trial Summary

The purpose of the study is to collect information on disease characteristics from adult patients diagnosed with fatty acid oxidation disorders (FAOD).

Clinical Trial Description

In this study there will be no drug intervention. The study will include a Baseline visit and a follow up visit scheduled at Month 4. At these visits medical history, safety assessments, concomitant medications, exercise tests and quality of life questionnaire data will be collected. ;

Study Design

Related Conditions & MeSH terms

Fatty Acid Oxidation Disorder

Clinical Trial Details

NCT number	NCT04482049
Study type	Observational
Source	Reneo Pharma Ltd
Contact
Status	Completed
Phase
Start date	January 15, 2021
Completion date	May 4, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04309214` - Market Research - Acceptability Study for New MCT Fat Products	N/A
Completed	`NCT04309149` - Market Research - Acceptability Study for a Range of MCT Products	N/A
Completed	`NCT04009642` - Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
Completed	`NCT04400422` - Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders	N/A
Recruiting	`NCT04602325` - Systemic Biomarkers of Brain Injury From Hyperammonemia